493 related articles for article (PubMed ID: 19802967)
1. Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
Phillips I; Warren C; Shannon K; King A; Hanslo D
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():23-31. PubMed ID: 19802967
[TBL] [Abstract][Full Text] [Related]
2. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
[TBL] [Abstract][Full Text] [Related]
3. Cefotetan: in-vitro antibacterial activity and susceptibility to beta-lactamases.
Phillips I; King A; Shannon K; Warren C
J Antimicrob Chemother; 1983 Jan; 11 Suppl():1-9. PubMed ID: 6601650
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the in-vitro antibacterial activity of Sch 34343.
Adam C; Naples L; Weiss W; Sabatelli F; Hare R; Loebenberg D; Miller GH
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():39-56. PubMed ID: 3875604
[TBL] [Abstract][Full Text] [Related]
5. In vitro antibacterial activity and susceptibility of the cephalosporin Ro 13-9904 to beta-lactamases.
Shannon K; King A; Warren C; Phillips I
Antimicrob Agents Chemother; 1980 Aug; 18(2):292-8. PubMed ID: 6969574
[TBL] [Abstract][Full Text] [Related]
6. The in-vitro properties of ceftazidime.
Harper PB
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():5-13. PubMed ID: 19802965
[TBL] [Abstract][Full Text] [Related]
7. In-vitro activity of ceftazidime against Pseudomonas aeruginosa: and its stability to pseudomonal beta-lactamases.
Livermore DM; Williams RJ; Williams JD
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():163-7. PubMed ID: 19802980
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of ceftazidime and other cephalosporins to a range of beta-lactamases and their potential as inducing agents.
Mouton RP; Bongaerts GP; van Gestel MH
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():147-52. PubMed ID: 19802978
[TBL] [Abstract][Full Text] [Related]
9. Comparative activity of ceftizoxime against aminoglycoside-resistant aerobic gram-negative bacilli.
Gómez-Lus R; Rubio MC; García C; Gómez-Lus ML; Alejandre MC
Drugs Exp Clin Res; 1987; 13(3):155-9. PubMed ID: 3497792
[TBL] [Abstract][Full Text] [Related]
10. Sch 34343: in-vitro antibacterial activity and susceptibility to beta-lactamases.
Shannon K; King A; Phillips I
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():15-23. PubMed ID: 3897169
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity and beta-lactamase stability of cefodizime, an aminothiazolyl iminomethoxy cephalosporin.
Scully BE; Jules K; Neu HC
Antimicrob Agents Chemother; 1983 Jun; 23(6):907-13. PubMed ID: 6311090
[TBL] [Abstract][Full Text] [Related]
12. Behaviour of ceftazidime towards beta-lactamases.
Labia R; Beguin-Billecoq R; Guionie M
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():141-6. PubMed ID: 19810176
[TBL] [Abstract][Full Text] [Related]
13. In-vitro activity of ceftazidime, a beta-lactamase stable cephalosporin.
Neu HC
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():131-4. PubMed ID: 19810175
[TBL] [Abstract][Full Text] [Related]
14. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
Hall WH; Opfer BJ; Gerding DN
Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activity, beta-lactamase stability and beta-lactamase inhibition of cefotetan and other 7-alpha-methoxy beta-lactam antimicrobials.
Jones RN; Wilson HW
Diagn Microbiol Infect Dis; 1983 Mar; 1(1):71-83. PubMed ID: 6323095
[TBL] [Abstract][Full Text] [Related]
16. The antimicrobial activity and beta-lactamase stability of cefpirome, a new fourth-generation cephalosporin in comparison with other agents.
Cheng AF; Ling TK; Lam AW; Fung KS; Wise R
J Antimicrob Chemother; 1993 May; 31(5):699-709. PubMed ID: 8335498
[TBL] [Abstract][Full Text] [Related]
17. An in-vitro comparison of new cephalosporins with special reference to Pseudomonas aeruginosa.
van Klingeren B
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():97-105. PubMed ID: 19810171
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of ceftazidime and ceftriaxone.
Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
[TBL] [Abstract][Full Text] [Related]
19. Comparative in-vitro activity of ceftazidime (GR-20263) and other beta-lactamase stable cephalosporins against anaerobic bacteria.
Chow AW; Bartlett KH
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():91-5. PubMed ID: 19802974
[TBL] [Abstract][Full Text] [Related]
20. The comparative in-vitro activity of pefloxacin.
King A; Phillips I
J Antimicrob Chemother; 1986 Apr; 17 Suppl B():1-10. PubMed ID: 2940213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
